comparemela.com
Home
Live Updates
Kyowa Kirin Announces Acceptance for Presentations at the European Academy of Dermatology and Venereology Congress 2023 : comparemela.com
Kyowa Kirin Announces Acceptance for Presentations at the European Academy of Dermatology and Venereology Congress 2023
Kyowa Kirin Co., Ltd. (TSE: 4151) announced that post-hoc analysis data from the Phase 2b study of rocatinlimab (AMG 451/KHK4083), an investigational product being studied in patients
Related Keywords
Berlin ,
Germany ,
Japan ,
Tokyo ,
United States ,
America ,
Ehsanollah Esfandiari ,
Hirotaka Mano ,
Kenji Kabashima ,
Emma Guttman Yassky ,
Asia Pacific ,
Camilla Chong ,
European Academy Of Dermatology ,
Jolla Institute For Immunology ,
A Global Specialty Pharmaceutical Company ,
Kyowa Kirin Us Research ,
Prnewswire Kyowa Kirin Co Ltd ,
Amgen ,
European Academy ,
Poster Title ,
Phd Date ,
Kyowa Kirin ,
Kyowa Kirin Collaborationon June ,
Kyowa Kirinkyowa Kirin ,
North America ,
Kyowa ,
Study ,
Data ,
comparemela.com © 2020. All Rights Reserved.